Vanguard reports zero MicroVision (MVIS) holdings after realignment
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 3 to Schedule 13G/A reporting 0 shares of MicroVision Inc. common stock as beneficially owned. The filing explains an internal realignment and disaggregation under SEC Release No. 34-39538 (January 12, 1998), with certain subsidiaries reporting separately. The amendment is signed by Ashley Grim on 03/27/2026.
Positive
- None.
Negative
- None.
FAQ
What did The Vanguard Group report for MVIS ownership?
The Vanguard Group reported beneficial ownership of 0 shares of MicroVision common stock. The amendment states subsidiaries were disaggregated after an internal realignment under SEC Release No. 34-39538, and reporting is now on a separate, disaggregated basis.
Why does the Schedule 13G/A amendment show zero holdings for MVIS?
The amendment attributes the change to an internal realignment and disaggregation of subsidiaries. The filing cites that subsidiaries formerly reported with The Vanguard Group now report separately in reliance on SEC Release No. 34-39538 (Jan 12, 1998) following the reorganization.
When was the Schedule 13G/A Amendment No.3 signed for MVIS?
The amendment was signed on 03/27/2026 by Ashley Grim, Head of Global Fund Administration. The filing includes a comment describing the January 12, 2026 internal realignment and the resulting disaggregated reporting.
Does the filing identify any other party with >5% ownership in MVIS?
No other person is identified as holding more than 5% of the class in this filing. The Vanguard Group states that no one else's interest in the reported securities exceeds 5% within the described reporting groups.
What is the reporting address for The Vanguard Group in this filing?
The Vanguard Group's principal business address is listed as 100 Vanguard Blvd., Malvern, PA 19355. The filing also shows MicroVision's principal executive offices at 6222 185th Ave NE, Redmond, WA 98052.